Michel Thépaut

Michel Thépaut

Auto-generated profile, based on publicly available information

Michel Thépaut

Centre National de la Recherche Scientifique

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 May 2021 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
MTMichel Thépaut
Michel Thépaut
JLJoanna Luczkowiak
Joanna Luczkowiak
CVCorinne Vivès
Corinne Vivès
NLNuria Labiod
Nuria Labiod
IBIsabelle Bally
Isabelle Bally
FFFranck Fieschi
Franck Fieschi
The efficient spread of SARS-CoV-2 resulted in a unique pandemic in modern history. Despite early identification of ACE2 as the receptor for viral spike protein, much remains to be understood about the molecular events behind viral dissemination. We evaluated the contribution of C-type lectin receptors (CLRS) of antigen-presenting cells, widely present in respiratory mucosa and lung tissue. DC-SIGN, L-SIGN, Langerin and MGL bind to diverse glycans of the spike using multiple interaction areas. Using pseudovirus and cells derived from monocytes or T-lymphocytes, we demonstrate that while virus capture by the CLRs examined does not allow direct cell infection, DC/L-SIGN, among these receptors, promote virus transfer to permissive ACE2+Vero E6 cells. A glycomimetic compound designed against DC-SIGN, enable inhibition of this process. These data have been then confirmed using authentic SARS-CoV-2 virus and human respiratory cell lines. Thus, we described a mechanism potentiating viral spreading of infection.

1 November 2021 in Journal of Colloid and Interface Science
Verified
Journal Article
Open access
YCYubexi Correa
Yubexi Correa
SWSarah Waldie
Sarah Waldie
MTMichel Thépaut
Michel Thépaut
SMSamantha Micciulla
Samantha Micciulla
MMMartine Moulin
Martine Moulin
MCMarité Cardenas
Marité Cardenas
Cholesterol has been shown to affect the extent of coronavirus binding and fusion to cellular membranes. The severity of Covid-19 infection is also known to be correlated with lipid disorders. Furthermore, the levels of both serum cholesterol and high-density lipoprotein (HDL) decrease with Covid-19 severity, with normal levels resuming once the infection has passed. Here we demonstrate that the SARS-CoV-2 spike (S) protein interferes with the function of lipoproteins, and that this is dependent on cholesterol. In particular, the ability of HDL to exchange lipids from model cellular membranes is altered when co-incubated with the spike protein. Additionally, the S protein removes lipids and cholesterol from model membranes. We propose that the S protein affects HDL function by removing lipids from it and remodelling its composition/structure.

2 October 2020 in Journal of Drug Targeting
Verified
Journal Article
Open access
LGLaura Gauthier
Laura Gauthier
MCMireille Chevallet
Mireille Chevallet
FBFrancois Bulteau
Francois Bulteau
MTMichel Thépaut
Michel Thépaut
PDPascale Delangle
Pascale Delangle
CGChristelle Gateau
Christelle Gateau
Liver is the main organ for metabolism but is also subject to various pathologies, from viral, genetic, cancer or metabolic origin. There is thus a crucial need to develop efficient liver-targeted drug delivery strategies. Asialoglycoprotein receptor (ASGPR) is a C-type lectin expressed in the hepatocyte plasma membrane that efficiently endocytoses glycoproteins exposing galactose (Gal) or N-acetylgalactosamine (GalNAc). Its targeting has been successfully used to drive the uptake of small molecules decorated with three or four GalNAc, thanks to an optimization of their spatial arrangement. Herein, we assessed the biological properties of highly stable nanostructured lipid carriers (NLC) made of FDA-approved ingredients and formulated with increasing amounts of GalNAc. Cellular studies showed that high density of GalNAc was required to favour hepatocyte internalization via the ASGPR pathway. Interaction studies using surface plasmon resonance and the Macrophage Galactose-Lectin as GalNAc-recognizing lectin confirmed the need of high GalNAc density for specific recognition of these NLC. This work is a first step for the development of efficient nanocarriers for prolonged liver delivery of active compounds.

Verified
Journal Article
Open access
PDF file
SASilvia Achilli
Silvia Achilli
JMJoão Gonçalo Tereno Monteiro
João Gonçalo Tereno Monteiro
SSSonia Serna
Sonia Serna
SMSabine Mayer-Lambertz
Sabine Mayer-Lambertz
MTMichel Thépaut
Michel Thépaut
CDCorinne Deniaud
Corinne Deniaud
C-type lectin receptor (CLR)/carbohydrate recognition occurs through low affinity interactions. Nature compensates that weakness by multivalent display of the lectin carbohydrate recognition domain (CRD) at the cell surface. Mimicking these low affinity interactions in vitro is essential to better understand CLR/glycan interactions. Here, we present a strategy to create a generic construct with a tetrameric presentation of the CRD for any CLR, termed TETRALEC. We applied our strategy to a naturally occurring tetrameric CRD, DC-SIGNR, and compared the TETRALEC ligand binding capacity by synthetic N- and O-glycans microarray using three different DC-SIGNR constructs i) its natural tetrameric counterpart, ii) the monomeric CRD and iii) a dimeric Fc-CRD fusion. DC-SIGNR TETRALEC construct showed a similar binding profile to that of its natural tetrameric counterpart. However, differences observed in recognition of low affinity ligands underlined the importance of the CRD spatial arrangement. Moreover, we further extended the applications of DC-SIGNR TETRALEC to evaluate CLR/pathogens interactions. This construct was able to recognize heat-killed Candida albicans by flow cytometry and confocal microscopy, a so far unreported specificity of DC-SIGNR. In summary, the newly developed DC-SIGNR TETRALEC tool proved to be useful to unravel novel CLR/glycan interactions, an approach which could be applied to other CLRs.

24 January 2022 in Cell Reports Medicine
Verified
Journal Article
Open access
GSGuidenn Sulbaran
Guidenn Sulbaran
PMPauline Maisonnasse
Pauline Maisonnasse
AAAxelle Amen
Axelle Amen
GEGregory Effantin
Gregory Effantin
DGDelphine Guilligay
Delphine Guilligay
Winfried WeissenhornWinfried Weissenhorn
Winfried Weissenhorn
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has caused an ongoing global health crisis. Here, we present as a vaccine candidate synthetic SARS-CoV-2 spike (S) glycoprotein-coated lipid vesicles that resemble virus-like particles. Soluble S glycoprotein trimer stabilization by formaldehyde cross-linking introduces two major inter-protomer cross-links that keep all receptor-binding domains in the “down” conformation. Immunization of cynomolgus macaques with S coated onto lipid vesicles (S-LVs) induces high antibody titers with potent neutralizing activity against the vaccine strain, Alpha, Beta, and Gamma variants as well as T helper (Th)1 CD4+-biased T cell responses. Although anti-receptor-binding domain (RBD)-specific antibody responses are initially predominant, the third immunization boosts significant non-RBD antibody titers. Challenging vaccinated animals with SARS-CoV-2 shows a complete protection through sterilizing immunity, which correlates with the presence of nasopharyngeal anti-S immunoglobulin G (IgG) and IgA titers. Thus, the S-LV approach is an efficient and safe vaccine candidate based on a proven classical approach for further development and clinical testing.

14 November 2023 in Chemistry – A European Journal
Verified
Journal Article
Open access
IHIrene Herrera‐González
Irene Herrera‐González
MGManuel González‐Cuesta
Manuel González‐Cuesta
MTMichel Thépaut
Michel Thépaut
ELEugénie Laigre
Eugénie Laigre
DGDavid Goyard
David Goyard
CMCarmen Ortiz Mellet
Carmen Ortiz Mellet
The “carbohydrate chemical mimicry” exhibited by sp2‐iminosugars has been utilized to develop practical syntheses for analogs of the branched high‐mannose‐type oligosaccharides (HMOs) Man3 and Man5. In these compounds, the terminal nonreducing Man residues have been substituted with 5,6‐oxomethylidenemannonojirimycin (OMJ) motifs. The resulting oligomannoside hemimimetic accurately reproduce the structure, configuration, and conformational behavior of the original mannooligosaccharides, as confirmed by NMR and computational techniques. Binding studies with mannose binding lectins, including concanavalin A, DC‐SIGN, and langerin, by enzyme‐linked lectin assay and surface plasmon resonance revealed significant variations in their ability to accommodate the OMJ unit in the mannose binding site. Intriguingly, OMJMan segments demonstrated “in line” heteromultivalent effects during binding to the three lectins. Similar to the mannobiose (Man2) branches in HMOs, the binding modes involving the external or internal monosaccharide unit at the carbohydrate binding‐domain exist in equilibrium, facilitating sliding and recapture processes. This equilibrium, which influences the multivalent binding of HMOs, can be finely modulated upon incorporation of the OMJ sp2‐iminosugar caps. As a proof of concept, the affinity and selectivity towards DC‐SIGN and langerin were adjustable by presenting the OMJMan epitope in platforms with diverse architectures and valencies.